HerefordSire
Well-known member
Further reasearch is required to produce the actual documents referred below. If you have trouble locating one, let me know and I will see if I can get the document.
New, cutting-edge research indicates even greater medical applications for nicotine:
"This study demonstrates that nicotine stimulates recovery from brain damage and the results are discussed in relation to neural mechanism and potential applications." (Brown RW, Gonzalez CL, Whishaw IQ, Kolb B, "Nicotine improvement of Morris water task performance after fimbria-fornix lesion is blocked by mecamylamine," Behav Brain Research, Mar 15, 2001.)
"The research, involving animal studies, showed that the nicotine agent created more new blood vessels in blocked arteries than any other known growth factor. The new agent could be used to treat failing hearts and limbs with poor circulation. It holds the potential for non-surgical heart by-pass procedures." (Company Press Release, "Research Indicating That Nicotine Holds Potential for Non-Surgical Heart By-Pass Procedures Honored by the American College of Cardiology," 3/17/00)
"Nicotine might be a surprising alternative someday for treating stubborn forms of tuberculosis….'The compound stopped the growth of tuberculosis in laboratory tests, even when used in small quantities,' said Saleh Naser, an associate professor of microbiology and molecular biology at UCF.... Naser said nicotine worked better than about 10 other substances also tested." ("Shocker: 'Villain' nicotine slays TB," Robyn Suriano, Orlando Sentinel, 5/22/01).
"In addition, nicotine can exert a neuroprotective effect by attenuation of AA-induced upregulation of nNOS metabolism. These data may have therapeutic implication for the treatment of acute spinal cord trauma." (Toborek M, Garrido R, Malecki A, Kaiser S, et al, "Nicotine Attenuates Arachidonic Acid-Induced Overexpression of Nitric Oxide Synthase in Cultured Spinal Cord Neurons," Experimental Neurology, 161(2), Feb 2000).
"According to a new study, nicotine may reduce cramping and other symptoms of colitis, a painful intestinal disease that affects hundreds of thousands of people in the U.S. and millions around the world. The study, published in the Annals of Internal Medicine (Mar 1, 1997), could lead to better treatment for the estimated 320,000 people who suffer from ulcerative colitis in the US." (AP, Mar 1, 1997).
Possible use of nicotine in the prevention of classical Kaposi's sarcoma with KS herpes virus infection. (Goedert J, Vitale F, Lorenzo G, Romano N, National Cancer Institute, "Classical Kaposi's Sarcoma With KS Herpes Virus Infection: Reduced Risk with Cigarette Smoking," Proceedings of the American Association for Cancer Research, Vol 42, March 2001).
Treatment of clinical depression. "That could mean a whole new arena for new antidepressant drugs. It's quite possible you could make derivatives of nicotine that wouldn't have the medical complications of nicotine but could prove very useful in the treatment of clinical depression." Dr. Alexander Glassman, chief of clinical psychopharmacology at Columbia University's New York State Psychiatric Institute (quoted in "Kicking Habit Kicks Up Depression," Neil Sherman, HealthScout, 6/19/01).
http://www.forces.org/evidence/pharma/gold.htm
New, cutting-edge research indicates even greater medical applications for nicotine:
"This study demonstrates that nicotine stimulates recovery from brain damage and the results are discussed in relation to neural mechanism and potential applications." (Brown RW, Gonzalez CL, Whishaw IQ, Kolb B, "Nicotine improvement of Morris water task performance after fimbria-fornix lesion is blocked by mecamylamine," Behav Brain Research, Mar 15, 2001.)
"The research, involving animal studies, showed that the nicotine agent created more new blood vessels in blocked arteries than any other known growth factor. The new agent could be used to treat failing hearts and limbs with poor circulation. It holds the potential for non-surgical heart by-pass procedures." (Company Press Release, "Research Indicating That Nicotine Holds Potential for Non-Surgical Heart By-Pass Procedures Honored by the American College of Cardiology," 3/17/00)
"Nicotine might be a surprising alternative someday for treating stubborn forms of tuberculosis….'The compound stopped the growth of tuberculosis in laboratory tests, even when used in small quantities,' said Saleh Naser, an associate professor of microbiology and molecular biology at UCF.... Naser said nicotine worked better than about 10 other substances also tested." ("Shocker: 'Villain' nicotine slays TB," Robyn Suriano, Orlando Sentinel, 5/22/01).
"In addition, nicotine can exert a neuroprotective effect by attenuation of AA-induced upregulation of nNOS metabolism. These data may have therapeutic implication for the treatment of acute spinal cord trauma." (Toborek M, Garrido R, Malecki A, Kaiser S, et al, "Nicotine Attenuates Arachidonic Acid-Induced Overexpression of Nitric Oxide Synthase in Cultured Spinal Cord Neurons," Experimental Neurology, 161(2), Feb 2000).
"According to a new study, nicotine may reduce cramping and other symptoms of colitis, a painful intestinal disease that affects hundreds of thousands of people in the U.S. and millions around the world. The study, published in the Annals of Internal Medicine (Mar 1, 1997), could lead to better treatment for the estimated 320,000 people who suffer from ulcerative colitis in the US." (AP, Mar 1, 1997).
Possible use of nicotine in the prevention of classical Kaposi's sarcoma with KS herpes virus infection. (Goedert J, Vitale F, Lorenzo G, Romano N, National Cancer Institute, "Classical Kaposi's Sarcoma With KS Herpes Virus Infection: Reduced Risk with Cigarette Smoking," Proceedings of the American Association for Cancer Research, Vol 42, March 2001).
Treatment of clinical depression. "That could mean a whole new arena for new antidepressant drugs. It's quite possible you could make derivatives of nicotine that wouldn't have the medical complications of nicotine but could prove very useful in the treatment of clinical depression." Dr. Alexander Glassman, chief of clinical psychopharmacology at Columbia University's New York State Psychiatric Institute (quoted in "Kicking Habit Kicks Up Depression," Neil Sherman, HealthScout, 6/19/01).
http://www.forces.org/evidence/pharma/gold.htm